Australian animal health firm Jurox is coming to Kansas City

06/03/2014 1:23 PM

06/03/2014 3:59 PM

An Australian animal health pharmaceutical company is opening its North American headquarters in Kansas City, a move that’s expected to bring 13 full-time jobs.

The company, Jurox Pty Ltd., chose Kansas City because of its reputation as a growing center for the animal health industry. The firm manufactures and markets more than 120 animal health products in 20 countries.

The new Kansas City office, in the American Century Tower II building at 4520 Main St., will serve several regional offices in the U.S.

In addition to its headquarters staff, Jurox plans to hire 31 employees for its other national offices.

“Kansas City is the obvious best location to launch Jurox’s U.S. operations,” John O’Brien, managing director of the firm, said in a statement Tuesday. “Kansas City’s reputation and resources in animal sciences provide advantages you can’t find elsewhere.”

The company is expected to invest $741,000 in its Kansas City operation, according to the Missouri Department of Economic Development. The state also is offering incentives based on the firm’s job creation and investment performance.

The move was praised by federal, state and local officials as well as the Kansas City Area Development Council. The council, a regional economic development organization, has been promoting the area as the Kansas City Animal Health Corridor to national and international companies.

“The KC Animal Health Corridor’s high concentration of animal health entities paired with accessibility to distribution service providers makes the area an ideal location for Jurox to growth their presence and succeed in the U.S.,” said Bob Marcusse, president and CEO of the development council.

To reach Kevin Collison, call 816-234-4289 or send email to kcollison@kcstar.com. Follow him on Twitter at kckansascity.

Videos

Join the discussion

is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service